Clever Leaves Holdings Inc. (CLVR)
- Previous Close
4.0500 - Open
4.2193 - Bid --
- Ask --
- Day's Range
3.9000 - 4.2300 - 52 Week Range
1.7160 - 9.6000 - Volume
6,044 - Avg. Volume
19,293 - Market Cap (intraday)
6.896M - Beta (5Y Monthly) 1.53
- PE Ratio (TTM)
-- - EPS (TTM)
-12.6300 - Earnings Date May 9, 2024 - May 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment cultivates, extracts, manufactures, commercializes, and distributes cannabinoid products comprising cannabis flowers, cannabidiol isolates, full spectrum and standardized extracts, and dry smokable flowers internationally. The Non-Cannabinoid segment formulates, manufactures, markets, sells, distributes, and commercializes nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, and oral solutions; and tetrahydrocannabinol flowers. The company serves retail distributors, pharmaceutical and cannabis companies, and pharmacies. Clever Leaves Holdings Inc. was founded in 2017 and is based in Tocancipá, Colombia.
cleverleaves.com296
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: CLVR
Performance Overview: CLVR
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CLVR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CLVR
Valuation Measures
Market Cap
6.90M
Enterprise Value
2.15M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.35
Price/Book (mrq)
0.28
Enterprise Value/Revenue
0.12
Enterprise Value/EBITDA
-0.13
Financial Highlights
Profitability and Income Statement
Profit Margin
-102.77%
Return on Assets (ttm)
-23.39%
Return on Equity (ttm)
-61.27%
Revenue (ttm)
17.42M
Net Income Avi to Common (ttm)
-19.8M
Diluted EPS (ttm)
-12.6300
Balance Sheet and Cash Flow
Total Cash (mrq)
6.83M
Total Debt/Equity (mrq)
8.62%
Levered Free Cash Flow (ttm)
-2.25M